Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma

Bibliographic Details
Main Authors: Jang, Geundoo, Yoon, Dok Hyun, Kim, Shin, Lee, Dae Ho, Lee, Sang-wook, Huh, Jooryung, Suh, Cheolwon
Format: Online
Language:English
Published: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128890/
id pubmed-3128890
recordtype oai_dc
spelling pubmed-31288902011-07-11 Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma Jang, Geundoo Yoon, Dok Hyun Kim, Shin Lee, Dae Ho Lee, Sang-wook Huh, Jooryung Suh, Cheolwon Original Article Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011-06 2011-06-21 /pmc/articles/PMC3128890/ /pubmed/21747882 http://dx.doi.org/10.5045/kjh.2011.46.2.103 Text en © 2011 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Jang, Geundoo
Yoon, Dok Hyun
Kim, Shin
Lee, Dae Ho
Lee, Sang-wook
Huh, Jooryung
Suh, Cheolwon
spellingShingle Jang, Geundoo
Yoon, Dok Hyun
Kim, Shin
Lee, Dae Ho
Lee, Sang-wook
Huh, Jooryung
Suh, Cheolwon
Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
author_facet Jang, Geundoo
Yoon, Dok Hyun
Kim, Shin
Lee, Dae Ho
Lee, Sang-wook
Huh, Jooryung
Suh, Cheolwon
author_sort Jang, Geundoo
title Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
title_short Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
title_full Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
title_fullStr Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
title_full_unstemmed Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
title_sort addition of rituximab to the chop regimen has no benefit in patients with primary extranodal diffuse large b-cell lymphoma
description
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128890/
_version_ 1611463574291480576